HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Carrier detection in X linked ocular albinism using linked DNA polymorphisms.

Abstract
Sixty two females at 50% carrier risk were assessed from 19 families affected by X linked ocular albinism (OA1). Twenty nine (47%) had definite fundus changes of the carrier state with a mud splattered fundus appearance and 23 (37%) had a normal ophthalmic examination. Ten (16%) had mild peripheral retinal pigmentary changes so that it was difficult to exclude the carrier state; six of these females were shown to be at low risk and only one at high risk of being a carrier by DNA analysis using linked DNA polymorphisms, including a highly informative dinucleotide repeat at the Kallmann locus. Mild peripheral retinal pigmentary changes are not a definite indication of carrier status and in 45 age matched female controls five (11%) had similar changes. No female with a clinically normal fundus was found to be at high risk by DNA analysis. Molecular genetic analysis improves the accuracy of carrier detection in OA1 families and should be considered if the clinical findings are equivocal.
AuthorsS J Charles, A T Moore, Y Zhang, R McMahon, D E Barton, J R Yates
JournalThe British journal of ophthalmology (Br J Ophthalmol) Vol. 78 Issue 7 Pg. 539-41 (Jul 1994) ISSN: 0007-1161 [Print] England
PMID7918264 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • DNA
Topics
  • Albinism, Ocular (genetics)
  • DNA (analysis)
  • Family Health
  • Female
  • Genetic Carrier Screening (methods)
  • Genetic Linkage
  • Heterozygote
  • Humans
  • Pedigree
  • Polymorphism, Restriction Fragment Length
  • Risk Factors
  • X Chromosome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: